The Role of FSH in Prostate Cancer: A Case Report

Publication date: July 2016 Source:Urology Case Reports, Volume 7 Author(s): Salvatore Catarinicchia, E. David Crawford Castrate Resistant Prostate Cancer (CRPC) is a difficult entity to treat in the spectrum of prostate cancer disease. Recently, Follicle Stimulating Hormone (FSH) has been shown to play an important part in the natural history of prostate cancer disease progression (Crawford et al., 2014). Here, we discuss a now deceased 94 year-old patient who illustrates the importance of this.
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research